on 31 Dec 1969
Last Applicant/ Owned by
Anji Pharmaceuticals Inc.
245 Main StreetCambridge MA 02143
US
Serial Number
2067973 filed on 06th Oct 2020
Registration Number
TMA1165765 registered on 15th Feb 2023
Registration expiry Date
06th Oct 2030Correspondent Address
130 Queens Quay EastEast Tower, Suite 809Toronto,
ONTARIO
CA
M5A0P6
Trademark usage description
pharmaceutical preparations for the treatment of autoimmune diseases and disorders, genetic diseases and disorders, oncological diseases and disorders Read More11
2067973
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 48 on 11th Aug 2022 | Agent Changed |
Submitted for opposition 22 on 22nd Mar 2022 | Search Recorded |
Submitted for opposition 20 on 22nd Mar 2022 | Examiner's First Report |
Submitted for opposition 223 on 22nd Mar 2022 | Total Provisional Refusal |
Submitted for opposition 256 on 04th Oct 2021 | Notification of Possible Opposition Sent |
Submitted for opposition 257 on 03rd Dec 2020 | Designation Notification - Madrid Protocol |
Submitted for opposition 1 on 02th Dec 2020 | Created |
Submitted for opposition 31 on 02th Dec 2020 | Formalized |
Submitted for opposition 228 on 06th Oct 2020 | International Registration |
Submitted for opposition 30 on 06th Oct 2020 | Filed |